
Sign up to save your podcasts
Or


We are in desperate need of new medicines for the major diseases facing us in the 21st century such as Alzheimer's and obesity. And we are running out of antibiotics that are effective against bacteria that are now resistant to many old varieties. As bringing new and improved drugs to patients becomes more difficult and more expensive - it can take 20 years and around $1 billion to bring a medicine to market.
In the second programme looking at the problem with drug discovery, Geoff Watts asks what can be done to get new pharmaceutical treatments to patients.
He discovers that the industry is risk averse and regulations to ensure that drugs are safe and effective are burdensome. But there are pilot projects to speed up the process.
Geoff finds out that the experts believe that there needs to be a fundamental change in the drug development process, and the key ingredient is collaboration - between industry and academia and between different drug companies. He also discovers that the medical charity, the Wellcome Trust, is putting money into the development of antibiotics, a field not of interest to many pharmaceutical companies.
(Image: Pills in a jar, Credit: Getty Images)
By BBC World Service4.4
940940 ratings
We are in desperate need of new medicines for the major diseases facing us in the 21st century such as Alzheimer's and obesity. And we are running out of antibiotics that are effective against bacteria that are now resistant to many old varieties. As bringing new and improved drugs to patients becomes more difficult and more expensive - it can take 20 years and around $1 billion to bring a medicine to market.
In the second programme looking at the problem with drug discovery, Geoff Watts asks what can be done to get new pharmaceutical treatments to patients.
He discovers that the industry is risk averse and regulations to ensure that drugs are safe and effective are burdensome. But there are pilot projects to speed up the process.
Geoff finds out that the experts believe that there needs to be a fundamental change in the drug development process, and the key ingredient is collaboration - between industry and academia and between different drug companies. He also discovers that the medical charity, the Wellcome Trust, is putting money into the development of antibiotics, a field not of interest to many pharmaceutical companies.
(Image: Pills in a jar, Credit: Getty Images)

7,699 Listeners

883 Listeners

1,054 Listeners

5,544 Listeners

1,798 Listeners

1,761 Listeners

1,034 Listeners

2,008 Listeners

601 Listeners

769 Listeners

91 Listeners

421 Listeners

415 Listeners

822 Listeners

762 Listeners

729 Listeners

229 Listeners

363 Listeners

474 Listeners

241 Listeners

3,168 Listeners

733 Listeners

113 Listeners

1,004 Listeners